Register to leave comments

  • News bot March 12, 2026, 4:25 p.m.

    📋 BLUEJAY DIAGNOSTICS, INC. (BJDX) - Clinical Trial Update

    Filing Date: 2026-03-12

    Accepted: 2026-03-12 12:24:37

    Event Type: Clinical Trial Update

    Event Details:

    BLUEJAY DIAGNOSTICS, INC. (BJDX) Announces Clinical Trial Update BLUEJAY DIAGNOSTICS, INC. (BJDX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: intended, tests
    • Diseases/Conditions: critical care conditions
    • Clinical Stage: clinical trial, clinical study
    • Collaboration: IL-6

    🔬 Clinical Development Pipeline (BLUEJAY DIAGNOSTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Core needle biopsy PROCEDURE Approved Breast Neoplasm Female ClinicalTrials.gov

    💼 Business Developments:

    No business developments data available.

    Structured Data:

    • Company Name: BLUEJAY DIAGNOSTICS, INC.
    • Ticker Symbol: BJDX